Astex Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

ASTX 0.0000
price chart
Pomerantz Announces Notice of Dismissal of Astex Pharmaceuticals, Inc. Class ...
NEW YORK, Nov. 11, 2014 (GLOBE NEWSWIRE) -- By order of the Delaware Court of Chancery dated November 5, 2014, the following notice is being published.
Related articles »  
James Manuso, chairman and CEO of Astex Pharmaceuticals Inc.
Background: Manuso, a self-described �Euro mutt,� joined SuperGen Inc. as a director in 2001 and became chairman and CEO of Astex Pharma after SuperGen's acquisition last summer of Astex Therapeutics Ltd. in the U.K. The 140-employee company has ...
Astex Pharmaceuticals Inc Stock Downgraded (ASTX)
ASTEX PHARMACEUTICALS INC has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Related articles »  
Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
Outline of the Tender Offer 1) Offeror in the Public Tender Offer Autumn Acquisition Corporation 2) Company Subject to the Public Tender Offer Astex Pharmaceuticals, Inc. 3) Type of Stock that is to be Acquired All issued and outstanding shares of ...
Related articles »  
Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)
In the 21st century investor's toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
Related articles »  
5 Reasons To Buy Astex Pharmaceuticals
Astex Pharmaceuticals has established a broad pipeline of small molecule, molecularly-targeted drugs using its drug discovery engine, Pyramid, which is also used to support the company's drug discovery collaborations with leading pharmaceutical company ...
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in ...
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced today its plan to submit an ...
Astex Pharma To Submit IND Application To FDA For ASTX727 - Quick Facts  RTT News
Related articles »  
Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum
We believe that Astex Pharmaceuticals' (NASDAQ:ASTX) shares represent an excellent buying opportunity. Despite positive recent developments at Astex, the company has seemingly gotten lost in the shuffle, with shares slumping sharply - more than 35 ...
Related articles »  
3 Things You Need to Know From Astex's Q2 Earnings
Astex Pharmaceuticals (NASDAQ: ASTX ) announced its second-quarter financial results on Thursday prior to the market open. The company reported a net loss of $0.04 per share, better than the average analysts' estimate of a $0.06-per-share loss. Here ...
Astex Pharmaceuticals Announces First Data Showing Early Combination ...
DUBLIN, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced data demonstrating for the first ...
Related articles »